| 000 | 01752 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515163533.0 | ||
| 264 | 0 | _c20090407 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a0394-6320 | ||
| 024 | 7 |
_a10.1177/039463200902200125 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVena, G A | |
| 245 | 0 | 0 |
_aA multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite project. _h[electronic resource] |
| 260 |
_bInternational journal of immunopathology and pharmacology _c |
||
| 300 |
_a227-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aGalluccio, A | |
| 700 | 1 | _aDe Simone, C | |
| 700 | 1 | _aMastrandrea, V | |
| 700 | 1 | _aBuquicchio, R | |
| 700 | 1 | _aLa Greca, S | |
| 700 | 1 | _aDattola, S | |
| 700 | 1 | _aPuglisi Guerra, A | |
| 700 | 1 | _aDonato, L | |
| 700 | 1 | _aCantoresi, F | |
| 700 | 1 | _aDe Pità , O | |
| 700 | 1 | _aPezza, M | |
| 700 | 1 | _aD Agostino, M | |
| 700 | 1 | _aVernaci, R | |
| 700 | 1 | _aMiracapillo, A | |
| 700 | 1 | _aValenti, G | |
| 700 | 1 | _aCassano, N | |
| 773 | 0 |
_tInternational journal of immunopathology and pharmacology _gvol. 22 _gno. 1 _gp. 227-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/039463200902200125 _zAvailable from publisher's website |
| 999 |
_c18747066 _d18747066 |
||